Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26F9NU5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,725
Award facts
- Contract value 100% obligated
- $28,724.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $28,724.61 firm fixed-price delivery order to AmerSourceBergen Drug Corp on January 30, 2026, for the supply of TALTZ 80 mg/ml autoinjector, with completion targeted for February 2, 2026. This is a non-set-aside competitive award with performance to be completed in Conshohocken, Pennsylvania. The delivery order was issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031. This primary IDC serves as the comprehensive vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerSourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, is a critical vendor in the federal medical supply chain, particularly for military and veteran healthcare systems. The company maintains extensive federal contract awards predominantly with the Defense Logistics Agency, supplying a comprehensive range of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for TALTZ, a biologic medication used in dermatology and rheumatology treatment, demonstrates the company's ongoing role in fulfilling essential pharmaceutical needs for Defense Health Agency beneficiaries and other government healthcare systems through competitively awarded contracts.
Quick answers
Who was awarded contract SPE2DR26F9NU5?
SPE2DR26F9NU5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9NU5 worth?
The government has obligated $28,725 on SPE2DR26F9NU5.
Is contract SPE2DR26F9NU5 an order under another contract?
Yes. SPE2DR26F9NU5 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NU5 competed?
The extent of competition for SPE2DR26F9NU5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award